Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 15/20 | 1.00 |
| ▸ | PDE4A | P27815 | 5/20 | 0.92 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.92 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | RAD52 | P43351 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5011400 | 0.96 | PDE4B (1.00) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5013128 | 0.95 | PDE4B (0.91) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5014735 | 0.94 | PDE4B (0.94) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5015894 | 0.94 | PDE4B (0.94) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5011549 | 0.92 | PDE4B (1.00) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5011411 | 0.92 | PDE4B (0.85) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5014745 | 0.91 | PDE4B (0.91) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL4046259 | 0.88 | PDE4B (1.00) | PDE4BPDE4APDE4DADRB2KDM4E | |
| SCHEMBL5012406 | 0.88 | PDE4B (1.00) | PDE4BPDE4APDE4DADRB2CYP2C9 | |
| SCHEMBL5012445 | 0.87 | PDE4B (0.82) | PDE4BPDE4APDE4DADRB2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080207645-A1 | Pyridothienopyrimidine Derivatives | PAGES SANTACANA LUIS MIGUEL | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207645-A1 | Pyridothienopyrimidine Derivatives | PDE4A, PDE5A, PDE3B | PDE4B 5/4885PDE4A 1/4885PDE4D 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.